Animal studies suggest that plasmin, likely through activation of MMP-2, may also liquefy the vitreous and be of particular benefit as an adjunct to small-gauge vitrectomy systems.
In turn, may facilitate both easier and increased vitreous removal during vitrectomy, while shortening duration of surgery.